Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for obviousness
Bayer v Teva: Drug patent found "the result of standard and routine considerations" ([2021] EWHC 2690 (Pat)) Bayer v Teva: Drug patent found "the result of standard and routine considerations" ([2021] EWHC 2690 (Pat)) Reviewed by Dr Rose Hughes on Sunday, November 28, 2021 Rating: 5
BREAKING: Supreme Court confirms no hard line on inventive step test in finding Cialis dosage patent obvious BREAKING: Supreme Court confirms no hard line on inventive step test in finding Cialis dosage patent obvious Reviewed by Dr Rose Hughes on Wednesday, March 27, 2019 Rating: 5
How do you protect patents from judicial and expert hindsight? How do you protect patents from judicial and expert hindsight? Reviewed by Annsley Merelle Ward on Thursday, March 29, 2018 Rating: 5
The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious Reviewed by Annsley Merelle Ward on Sunday, November 05, 2017 Rating: 5
Conference Report: Zurich IP Retreat 2017 - Patents and Hindsight (Part II) Conference Report: Zurich IP Retreat 2017 - Patents and Hindsight (Part II) Reviewed by Mark Schweizer on Monday, September 18, 2017 Rating: 5
Conference Report: Zurich IP Retreat 2017 - Patents and Hindsight (Part I) Conference Report: Zurich IP Retreat 2017 - Patents and Hindsight (Part I) Reviewed by Mark Schweizer on Monday, September 18, 2017 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.